Susquehanna International Group, LLP Elevation Oncology, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 37,925 shares of ELEV stock, worth $10,998. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,925Holding current value
$10,998% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ELEV
# of Institutions
71Shares Held
39.1MCall Options Held
100Put Options Held
3.3K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$1.74 Million0.21% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$1.38 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.53MShares$1.02 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA2.97MShares$860,3820.06% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$822,1230.6% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $6.76M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...